BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27824706)

  • 1. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
    McCawley N; Clancy C; O'Neill BD; Deasy J; McNamara DA; Burke JP
    Dis Colon Rectum; 2016 Dec; 59(12):1200-1208. PubMed ID: 27824706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials.
    Owens PW; Saeed M; McCawley N; Loughlin P; Kearney DE; Burke JP; McNamara DA; Sahebally SM
    Surgeon; 2024 Jun; 22(3):166-173. PubMed ID: 38521683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis.
    Shen H; Jin Z; Chen Q; Zhang L; You J; Zhang S; Zhang B
    Radiol Med; 2024 Apr; 129(4):598-614. PubMed ID: 38512622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of tumor budding in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis.
    Li J; Ma Y; Wen L; Zhang G; Huang C; Wang J; Yao X
    Syst Rev; 2024 Jan; 13(1):22. PubMed ID: 38191437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study.
    Sun YW; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Wang XJ
    Gastroenterol Res Pract; 2017; 2017():5715219. PubMed ID: 28400820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Outcome of surgery after total neoadjuvant treatment in comparison to standard chemoradiotherapy of rectal cancer: a meta-analysis].
    Germer CT; Reibetanz J
    Chirurgie (Heidelb); 2024 Jun; 95(6):489-490. PubMed ID: 38700559
    [No Abstract]   [Full Text] [Related]  

  • 7. Mucinous Differentiation in Colorectal Cancer: A 10-Year Experience Audit at King Faisal Specialist Hospital and Research Centre, Jeddah.
    Alshehri KA; Alsulaimani N; Alghamdi WA; Almansouri Z; Zubair SA; Zekri J; Saimeh H; Sultan S
    Cureus; 2024 Mar; 16(3):e56722. PubMed ID: 38646258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer.
    Yu G; Chi H; Zhao G; Wang Y
    Front Oncol; 2024; 14():1375334. PubMed ID: 38638858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross morphologic features of surgical specimen in rectal cancer patients with pathological complete response following neoadjuvant chemoradiotherapy: A cross-sectional study.
    Fazeli AR; Tadbir Vajargah K; Fazeli MS; Behboudi B; Ahmadi-Tafti SM; Kazemeini A; Keshvari A; Keramati MR
    World J Surg; 2024 May; ():. PubMed ID: 38794790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer.
    Duggan WP; Kisakol B; Woods I; Azimi M; Dussmann H; Fay J; O'Grady T; Maguire B; Reynolds IS; Salvucci M; Slade DJ; McNamara DA; Burke JP; Prehn JHM
    Gut Microbes; 2024; 16(1):2350149. PubMed ID: 38709233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.
    Nikas JB; Lee JT; Maring ED; Washechek-Aletto J; Felmlee-Devine D; Johnson RA; Smyrk TC; Tawadros PS; Boardman LA; Steer CJ
    Am J Cancer Res; 2015; 5(10):3231-40. PubMed ID: 26693073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waist subcutaneous soft tissue metastasis of rectal mucinous adenocarcinoma: A case report.
    Gong ZX; Li GL; Dong WM; Xu Z; Li R; Lv WX; Yang J; Li ZX; Xing W
    World J Clin Cases; 2024 May; 12(14):2412-2419. PubMed ID: 38765752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
    Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
    Eur Radiol; 2024 Jan; ():. PubMed ID: 38240808
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Kulaylat AS; Hollenbeak CS; Stewart DB
    Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.
    Perez EA; Barrios C; Eiermann W; Toi M; Im YH; Conte P; Martin M; Pienkowski T; Pivot X; Burris H; Petersen JA; Stanzel S; Strasak A; Patre M; Ellis P
    J Clin Oncol; 2017 Jan; 35(2):141-148. PubMed ID: 28056202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.
    Nagtegaal ID; Knijn N; Hugen N; Marshall HC; Sugihara K; Tot T; Ueno H; Quirke P
    J Clin Oncol; 2017 Apr; 35(10):1119-1127. PubMed ID: 28029327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options.
    Luo C; Cen S; Ding G; Wu W
    Cancer Commun (Lond); 2019 Mar; 39(1):13. PubMed ID: 30922401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy.
    Cao W; Wu L; Zhao Y; Zhou J; Li W; Wang X; Xu J; Zhou Z; Liang C
    Front Oncol; 2020; 10():1425. PubMed ID: 32974154
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer.
    Reynolds IS; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Furney SJ; Burke JP
    Pharmacogenomics J; 2020 Jun; 20(3):524-532. PubMed ID: 31819162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
    Sun Y; Huang Z; Chi P
    Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.